As is well-known by now, health insurance premiums, especially on the reform law exchanges, are beginning to rise more rapidly. The obvious cause for this is more use of medical services. An analysis from consulting and policy firm Avalere examines what service categories are contributing to the increase in premiums. (Avalere Report) Avalere examined rate filings in nine states, mostly mid-Atlantic and Northeast, for the individual and small group markets. These rate filings contain the insurers justifications for the requested premiums. Six categories of cost were examined, inpatient, outpatient hospital, professional services, drugs, capitation payments and other. The 2017 filings were compared to those for 2016 and to actual expenses in 2015. Given all the hubbub about drug prices, particularly for specialty medications, it was a little surprising to learn that the largest contributor to premium increases for 2017 will be outpatient services, although given what hospitals are doing in the outpatient arena, maybe it shouldn’t be surprising. Although the trends vary by state, overall outpatient spending accounts for 30% of rate increase justifications. The outpatient category represents 27% of actual spending in 2015. Both the contribution to premium increases and to actual health plan costs was similar to that in earlier years. In 2015 plans spend 18% of premiums on prescription medications, and they account for 14% of premium growth in 2017 filings. Inpatient hospital is 20% of spending, but only a 15% contributor to 2017 rate rises. Other, which includes lab, radiology and other miscellaneous services, is only 5% of spending but is growing more rapidly, accounting for 10% of the premium increase. These state filings give a very good sense of where health plans are actually seeing cost increases, whether due to unit prices or utilization, and also often give utilization data.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Mental health company Headway makes, well, headway, by raising an impressive $125 million round of new capital. The company connects patients with mental health providers and facilitates providers working with...
October 11, 2023
Two health care firms owned by private equity firms are merging in a transaction supposedly valued at $3 billion. HealthComp administers self-funded plans for employers and other groups and Virgin...
September 27, 2023
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace